New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine
Researchers at the BioMed X Institute and the Universitätsmedizin Mannheim just published the results of their collaboration around a new neoepitope vaccine in diffuse midline...
BioMed X Launches New T Cell Immunology Discovery Platform
A new technology developed by BioMed X in collaboration with Janssen functionally identifies and validates T cell target antigens, making it a powerful tool for...